MedTrace Logo

Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men

NCT00700024 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-09-21

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of training and testim on Hypogonadism.

Conditions

  • Hypogonadism
  • Metabolic Syndrome

Interventions

DRUG

Testim

50 mg/dose7day

BEHAVIORAL

Strength training

three times a week

DRUG

placebo

placebo

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Marianne Andersen, Md, phd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
78 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-01-31
Completion
2010-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700024 on ClinicalTrials.gov